102 avenue Gaston Roussel
6 articles with Pherecydes Pharma
Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
Pherecydes Pharma and BIOASTER, the French Technology Research Institute for Microbiology and Infectious Diseases, announce the signing of a collaboration agreement.
Phage therapy could offer an alternative treatment method in the fight against antimicrobial resistance
With this financial support, the company plans to produce phages for compassionate use in accordance with GMP.
Antibiotic Resistance: Pherecydes Pharma Appoints Guy-Charles Fanneau De La Horie As Chief Executive Officer
A World First: Pherecydes Pharma Launches Multicenter Clinical Study Of Phage Therapy In Serious Burn Victims
Pherecydes Pharma Secures DGA Funding for Evaluating the Use of Bacteriophages Against Infected, Antibiotic Resistant Burns